Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
DILTIAZEM HYDROCHLORIDE
MARCAN PHARMACEUTICALS INC
C08DB01
DILTIAZEM
120MG
CAPSULE (EXTENDED RELEASE)
DILTIAZEM HYDROCHLORIDE 120MG
ORAL
30/90/1000
Prescription
MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS
Active ingredient group (AIG) number: 0115863004; AHFS:
APPROVED
2017-06-21
_Mar-Diltiazem T (Diltiazem HCl) Page 1 of 36 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR MAR-DILTIAZEM T Diltiazem Hydrochloride Extended-Release Capsules Extended-Release Capsules, 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, Oral USP ANTIHYPERTENSIVE AGENT ANTIANGINAL AGENT Marcan Pharmaceuticals Inc. 2 Gurdwara Road, Suite #112 Ottawa ON, K2E1A Date of Initial Authorization: June 21, 2017 Date of Revision: July 21, 2023 Submission Control Number: 272116 _Mar-Diltiazem T (Diltiazem HCl) _ _Page 2 of 36 _ RECENT MAJOR LABEL CHANGES 2. CONTRAINDICATIONS 07/2023 TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. TABLE OF CONTENTS ..................................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION ............................................................... 4 1 INDICATIONS .................................................................................................................... 4 1.1 Pediatrics ............................................................................................................................. 4 1.2 Geriatrics ............................................................................................................................. 4 2 CONTRAINDICATIONS ..................................................................................................... 4 4 DOSAGE AND ADMINISTRATION................................................................................... 5 4.1 Dosing Considerations ................................................................................................................... 5 4.2 Recommended Dose and Dosage Adjustment ........................................................................5 4.4 Administration..................................................................................................................... 5 4.5 Missed Dose .................................. Կարդացեք ամբողջական փաստաթուղթը